NCT06451315

Brief Summary

The team hypothesizes that fully automatic analysis of AAA could provide increased performance (decreased duration of segmentation with increased reproducibility and decreased inter and intraobserver variability) to detect aortic aneurysmal sac enlargement (volumes and diameters) and predict the risk of complications during the procedure and during follow-up (MAE, MACE, MALE, Stroke) compared to standard methods of measurement relying on approximate maximum sac diameter.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 30, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 31, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 11, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2024

Completed
Last Updated

June 13, 2024

Status Verified

May 1, 2024

Enrollment Period

6 months

First QC Date

May 31, 2024

Last Update Submit

June 11, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • global volume measure of the aneurysm

    global volume measure of the aneurysm by CT-scan. Data are retrospectively collected from the preoperative period (6 months before intervention), during hospitalisation and at systematic follow-up visits at 3, 6 and 12 months after surgery.

    6 months before surgery

  • global volume measure of the aneurysm

    global volume measure of the aneurysm by CT-scan. Data are retrospectively collected from the preoperative period (6 months before intervention), during hospitalisation and at systematic follow-up visits at 3, 6 and 12 months after surgery.

    Day 3

  • global volume measure of the aneurysm

    global volume measure of the aneurysm by CT-scan. Data are retrospectively collected from the preoperative period (6 months before intervention), during hospitalisation and at systematic follow-up visits at 3, 6 and 12 months after surgery.

    Month 3

  • global volume measure of the aneurysm

    global volume measure of the aneurysm by CT-scan. Data are retrospectively collected from the preoperative period (6 months before intervention), during hospitalisation and at systematic follow-up visits at 3, 6 and 12 months after surgery.

    Month 6

  • global volume measure of the aneurysm

    global volume measure of the aneurysm by CT-scan. Data are retrospectively collected from the preoperative period (6 months before intervention), during hospitalisation and at systematic follow-up visits at 3, 6 and 12 months after surgery.

    Month 12

Secondary Outcomes (15)

  • lumen volume measure of the aneurysm

    6 months before surgery

  • lumen volume measure of the aneurysm

    Day 3

  • lumen volume measure of the aneurysm

    Month 3

  • lumen volume measure of the aneurysm

    Month 6

  • lumen volume measure of the aneurysm

    Month 12

  • +10 more secondary outcomes

Study Arms (1)

Abdominal Aortic Aneurysm (AAA) treated with EndoVascular Aneurysm Repair (EVAR)

Male or female ≥18 years of age with AAA treated with EVAR between ≥50mm or ≥5mm increase in 6 months. The subject is legally competent, has been informed of the nature, the scope, and the relevance of the study and has not manifested an opposition to participate. He is available for set-up and proper implementation of follow-up visits (standard of care) throughout the duration of the registry

Procedure: Analyze CTscans pre-operatively by Nurea SystemProcedure: Analyze CTscans pre-operatively by hospital practitioner

Interventions

CTscans will be analyzed pre-operatively (6 months before intervention) and post-operatively with an early control scan (up to one-month post-EVAR), compared to a 3, 6 and 12-month control scan by system develop by Nurea

Abdominal Aortic Aneurysm (AAA) treated with EndoVascular Aneurysm Repair (EVAR)

CTscans will be analyzed pre-operatively (6 months before intervention) and post-operatively with an early control scan (up to one-month post-EVAR), compared to a 3, 6 and 12-month control scan by an hospital practitioner

Abdominal Aortic Aneurysm (AAA) treated with EndoVascular Aneurysm Repair (EVAR)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The patient came to the vascular surgery unit for his post-operative follow-up visit who have had surgery for Abdominal Aortic Aneurysm

You may qualify if:

  • Male or female ≥18 years of age
  • AAA treated with EVAR between
  • ≥50mm
  • or ≥5mm increase in 6 months
  • The subject is legally competent, has been informed of the nature, the scope, and the relevance of the study and has not manifested an opposition to participate.
  • Available for set-up and proper implementation of follow-up visits (standard of care) throughout the duration of the registry

You may not qualify if:

  • Advancing Alzheimer's disease or socially dependent patient
  • Opposition to the use of their data for this research
  • Life expectancy supposed to be inferior to 2 years
  • Pregnant woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Chirurgie Vasculaire, Hôpital Pellegrin-tripode, CHU de Bordeaux

Bordeaux, 33076, France

RECRUITING

MeSH Terms

Conditions

Aortic Aneurysm, Abdominal

Condition Hierarchy (Ancestors)

Aortic AneurysmAneurysmVascular DiseasesCardiovascular DiseasesAortic Diseases

Study Officials

  • Eric DUCASSE, MD, PhD

    University Hospital, Bordeaux

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2024

First Posted

June 11, 2024

Study Start

January 30, 2024

Primary Completion

July 15, 2024

Study Completion

July 15, 2024

Last Updated

June 13, 2024

Record last verified: 2024-05

Locations